IDXG Interpace Biosciences Inc
- 2.650
- -0.250-8.62%
Interpace Biosciences Inc News
10-Q: Q3 2024 Earnings Report
8-K: Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results
Interpace Biosciences Reports Impressive Q3 2024 Growth
Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results
Express News | Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq
10-Q: Q2 2024 Earnings Report
8-K: Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
Interpace Biosciences GAAP EPS of $0.48, Revenue of $12M
Earnings Flash (IDXG) INTERPACE BIOSCIENCES Posts Q2 Revenue $12M
Express News | Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
Express News | Interpace Biosciences Q2 Operating Expenses USD 5.174 Million
Express News | Interpace Biosciences Q2 Revenue USD 12.001 Million
Express News | Interpace Biosciences Q2 Net Income USD 2.021 Million
Express News | Interpace Biosciences Q2 Gross Profit USD 7.39 Million
Express News | Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for Pancragen®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts
Express News | Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an Asco 2024 Abstract
8-K: Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
10-Q: Q1 2024 Earnings Report
Express News | Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
Express News | Interpace Biosciences Q1 Gross Profit USD 6.071 Million
No Data